Skip to main content

Table 9 Dose response—antibodies (log10 mIU/mL)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Dose-IU

Number of individuals

Average time (days)

GMT day 0

GMT PV 30–45 days

31

92

27 (21–34)

2.12

2.99

158

88

27 (20–34)

2.14

3.68

587

92

28 (21–34)

2.16

4.02

3013

100

28 (21–34)

2.14

3.98

10,447

91

28 (21–34)

2.19

4.10

27,476

98

27 (21–34)

2.23

4.09